Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
You can purchase shares of Pliant Therapeutics (NASDAQ:PLRX) through any online brokerage.
Other companies in Pliant Therapeutics’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), SNDL (NASDAQ:SNDL), Xeris Biopharma Holdings (NASDAQ:XERS) and Phibro Animal Health (NASDAQ:PAHC).
Pliant Therapeutics has a consensus price target of $40.62.
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $14.67 last updated December 18, 2024 at 1:45 PM EST.
There are no upcoming dividends for Pliant Therapeutics.
Pliant Therapeutics’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
There is no upcoming split for Pliant Therapeutics.
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.